Quantamental Technologies’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantamental Technologies’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$248K	–	506
2022 Q2	$248K	Sell	500 -1,124	-69%	-$585K	0.11%	303
2022 Q1	$915K	Buy	+1,624	New	+$979K	0.53%	38
2020 Q3	–	Sell	-1,971	Closed	-$890K	–	264
2020 Q2	$890K	Buy	+1,971	New	+$870K	0.59%	52
2020 Q1	–	Sell	-2,060	Closed	-$762K	–	144
2019 Q4	$762K	Buy	+2,060	New	+$726K	0.39%	62
2019 Q2	–	Sell	-1,005	Closed	-$307K	–	1476
2019 Q1	$307K	Sell	1,005 -1,500	-60%	-$405K	0.14%	232
2018 Q4	$582K	Buy	+2,505	New	+$672K	0.35%	26

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quantamental Technologies's BIO Position: Q3 2022 in Review

Quantamental Technologies sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 500 shares — an estimated $248K sold.

Quantamental Technologies first reported a position in BIO in Q4 2018 and held it in 6 quarters. The position peaked at $915K in Q1 2022. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

Quantamental Technologies reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
Quantamental Technologies sold 500 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $248K.
Quantamental Technologies first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and held it in 6 quarters.
Quantamental Technologies's Bio-Rad Laboratories Class A position peaked at $915K in Q1 2022.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.